Another view of "humanitarian ventures" and "fistula tourism".

PubWeight™: 0.90‹?›

🔗 View Article (PMID 17252312)

Published in Int Urogynecol J Pelvic Floor Dysfunct on January 25, 2007

Authors

Mark A Morgan

Articles by these authors

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study. Lancet Oncol (2012) 2.14

Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse. J Urol (2005) 1.65

A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol (2005) 1.49

Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J Urol (2005) 1.30

Cervical cancer. J Natl Compr Canc Netw (2013) 1.24

Acute urinary retention caused by a uterine leiomyoma: a case report. J Reprod Med (2004) 1.16

Cervical cancer. J Natl Compr Canc Netw (2010) 1.07

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma. Hum Gene Ther (2005) 1.06

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunol Immunother (2011) 1.06

Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol (2003) 1.05

Pelvic organ prolapse, constipation, and dietary fiber intake in women: a case-control study. Am J Obstet Gynecol (2005) 1.05

Cervical cancer screening. J Natl Compr Canc Netw (2010) 0.87

Phase II trial of pyrazoloacridine in recurrent platinum-resistant ovarian cancer: a Gynecologic Oncology Group study. Am J Clin Oncol (2002) 0.86

Sexual function in women after rectocele repair with acellular porcine dermis graft vs site-specific rectovaginal fascia repair. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.85

Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study. J Clin Oncol (2003) 0.84

Vaginal erosion after pubovaginal sling procedures using dermal allografts. J Urol (2003) 0.84

Conservative management of vesicouterine fistula after uterine rupture. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.80

Comment on Wall et al.: "Ethical aspects of urinary diversion for women with irreparable obstetric fistulas in developing countries". Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.80

Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol (2005) 0.79

Combined anal sphincteroplasty and perineal reconstruction for fecal incontinence in women. J Am Osteopath Assoc (2009) 0.79

Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol (2005) 0.78

Depression in acute coronary syndrome: has the evidence been implemented? Aust J Rural Health (2008) 0.77

Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells. J Immunother (2017) 0.76

Re: no good options. J. A. Smith, Jr. J Urol 2011; 185: 8-9. J Urol (2011) 0.75

Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol (2007) 0.75

Intraperitoneal chemotherapy for ovarian cancer. Adv Exp Med Biol (2008) 0.75